Jequier A M
Department of Obstetrics and Gynaecology, University of Nottingham, University Hospital, Queens Medical Centre.
Aust N Z J Obstet Gynaecol. 1990 May;30(2):176-8. doi: 10.1111/j.1479-828x.1990.tb03257.x.
Two patients with resistant ovary syndrome are described. Both patients conceived while on hormone replacement therapy. Both women were taking the phasic preparation containing mestranol and norethisterone known as 'Menophase' (Syntex Pharmaceuticals Ltd). The possible mechanism of action of this type of hormone preparation in the induction of ovulation in patients with resistant ovary syndrome is discussed.
本文描述了两名患有抵抗性卵巢综合征的患者。两名患者均在接受激素替代治疗期间受孕。两名女性均服用了含有炔雌醇甲醚和炔诺酮的阶段性制剂,即“Menophase”(先灵葆雅制药有限公司)。本文还讨论了这类激素制剂在诱导抵抗性卵巢综合征患者排卵中的可能作用机制。